Intercept Pharmaceuticals is a biopharmaceutical company focused on developing and delivering novel medicines for people living with rare and serious liver diseases. The company has pioneered a scientific platform centered around Farnesoid X Receptor (FXR) biology, which has applications for conditions like primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis. Intercept is committed to progressing its research portfolio and advancing treatments for liver diseases by addressing high unmet medical needs. With a team dedicated to innovation and collaboration, the company aims to have a significant impact on therapeutic development and patient care. Headquartered in Morristown, NJ, Intercept is known for its FDA-approved FXR agonist used in second-line treatment of PBC.
Non-viral Liver Diseases β’ Rare Diseases β’ Biotechnology β’ Innovation
201 - 500 employees
Founded 2002
𧬠Biotechnology
π Pharmaceuticals
π¬ Science
π° $44.8M Convertible Note on 2016-06
Yesterday
Director of Market Access & Reimbursement for the West Region at Intercept, optimizing access for liver disease treatments.
π΅ Arizona β Remote
π California β Remote
+2 more states
π΅ $230k - $270k / year
π° $44.8M Convertible Note on 2016-06
β° Full Time
π΄ Lead
π Director
March 4
Seeking Senior Director for US Field Medical Affairs at a biopharmaceutical company focused on liver diseases.
πΊπΈ United States β Remote
π΅ $260k - $310k / year
π° $44.8M Convertible Note on 2016-06
β° Full Time
π Senior
π Director
Remote Jobs at Intercept Pharmaceuticals